Trial Profile
Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Mar 2013
Price :
$35
*
At a glance
- Drugs Safinamide (Primary) ; Ketoconazole
- Indications Alzheimer's disease; Drug-induced dyskinesia; Epilepsy; Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Merck KGaA; Merck Serono
- 25 Mar 2013 New trial record